Assessment of intestinal absorption of total flavones of Hippophae rhamnoides L. in rat using in situ absorption models.
OBJECTIVE
The objective of this study was to investigate the absorption behavior of total flavones of Hippophae rhamnoides L. (TFH) (the sum of isorhamnetin and quercetin as the index component) in the rat intestine using in situ circulation method.


METHODS
The accumulated TFH absorption and related absorption parameters were calculated. Furthermore, the influences of Cremophor ELP and the P-glycoprotein inhibitor, verapamil, on the intestinal absorption of TFH were studied using the in situ circulation model.


CONCLUSIONS
The results showed that the absorption of TFH increased linearly with its concentration, indicating that a passive diffusion process was dominated. There were no significant differences in the absorption of TFH in three small intestine segments of duodenum, jejunum, and ileum and at different concentrations of Cremophor ELP ranging from 0.25% to 1% (P > 0.05). With the presence of P-gp inhibitor, verapamil, in the circulation fluid, the accumulated absorption of TFH did not increase significantly (P > 0.05). Further studies on the solubility and permeability enhancement of TFH should be investigated to develop new TFH products with high bioavailability.
Science and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China.
Yan
Y
Xie
Xiaoli
X
Zeng
Guowen
G
Li
Zhenzhen
Z
Cai
Ning
N
Ding
Guang
G
Ji
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D000042:Absorption; D000818:Animals; D000959:Antihypertensive Agents / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology; D001682:Biological Availability; D004355:Drug Stability; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D047309:Flavones / Q000737:chemistry / Q000493:pharmacokinetics* / Q000494:pharmacology; D031281:Hippophae / Q000737:chemistry* / Q000378:metabolism*; D007408:Intestinal Absorption / Q000187:drug effects; D007421:Intestine, Small / Q000378:metabolism*; D008297:Male; D011092:Polyethylene Glycols / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014700:Verapamil / Q000494:pharmacology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000959:Antihypertensive Agents; D004365:Drugs, Chinese Herbal; D047309:Flavones; C022131:cremophor; D011092:Polyethylene Glycols; D014700:Verapamil